Nakanishi (7716) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales rose 36.4% year-over-year to ¥38,557 million for the six months ended June 30, 2024, with EBITDA up 17.8% and operating income up 3.1%.
Ordinary income declined 4.7% and net income attributable to owners of parent fell 11.9% year-over-year.
Comprehensive income surged 38.9% year-over-year, driven by strong foreign currency translation gains.
Financial highlights
Gross profit increased to ¥22,863 million from ¥17,793 million year-over-year.
Operating income reached ¥8,287 million, up from ¥8,038 million a year earlier.
Net income attributable to owners of parent was ¥7,027 million, down from ¥7,972 million year-over-year.
EPS for the period was ¥82.88, compared to ¥93.74 in the prior year.
Cash and cash equivalents at period-end were ¥30,133 million, up ¥4,160 million from the previous year-end.
Outlook and guidance
Full-year net sales forecast revised to ¥75,208 million (+26.0% year-over-year).
Operating income projected at ¥13,427 million (-5.8% year-over-year), and net income at ¥9,652 million (-57.7%).
EPS for the full year forecast at ¥113.85.
Dividend forecast raised to ¥52.00 per share for the year.
Latest events from Nakanishi
- Acquisition boosts U.S. market share and raises FY2026 sales and profit forecasts.7716
Acquisition presentation16 Mar 2026 - Net sales up 5.4% YoY, but DCI impairment led to a net loss; record sales and profit forecast for FY2026.7716
Q4 202512 Feb 2026 - Net sales up 3.8% YoY, but EBITDA and net income declined; guidance unchanged.7716
Q3 20256 Nov 2025 - Surgical growth offset flat sales, but net income dropped 50% amid currency headwinds.7716
Q2 20258 Aug 2025 - Sales surged 37.4% but net profit dropped 63.7%; outlook and dividend steady.7716
Q3 202413 Jun 2025 - Sales rose, but profits plunged on forex and tax hits; outlook lowered amid global risks.7716
Q1 20256 Jun 2025 - Record sales, sharp profit drop; FY2025 sees higher dividend and cautious outlook.7716
Q4 20245 Jun 2025